## Abstract We report a new vaccination strategy for squamous cell carcinoma (SCC). The vaccine was prepared by transfer of unfractionated DNAβfragments (25 kb) from squamous carcinoma cells (KLN205, DBA/2 origin (Hβ2^d^)) into LM mouse fibroblasts (C3H/He origin; Hβ2^k^), a highly immunogenic cell
Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells
β Scribed by O-Sullivan, InSug; Ng, Lauren K; Martinez, Don M; Kim, Tae S; Chopra, Amla; Cohen, Edward P
- Book ID
- 110019250
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 295 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0929-1903
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lymphocyte stimulation with Con A and specific immune reactivity to BCG (antibody formation to BCG and DTH reaction to PPD) were determined in BCG-treated, surgically treated and untreated cows with ocular squamous cell carcinoma. In tumor-bearing cows the Con A-induced proliferation of lymphocytes
## Abstract ## Background Overexpression of epidermal growth factor receptor (EGFR) is common in head and neck squamous cell carcinoma (HNSCC). Targeting EGFR is an effective approach to treat EGFRβpositive HNSCC. However, the clinical benefits of the present EGFRβtargeting agents are still limite
High-molecular-weight genomic DNA isolated from a human cutaneous squamous cell carcinoma (AS) was assayed for its ability to induce tumorigenic transformation of NIH 3T3 cells. Subcutaneous injection of NIH 3T3 cells cotransfected with DNAs from AS tumor and pSV2-neo plasmid not only induced tumors